Pulmonary Arterial Hypertension: Stepped, Novel, and Multidisciplinary Approaches to Management is organized by Healio, Vindico Medical Education.
Release Date: November 30, 2023
Expiration Date: November 29, 2024
Activity Description:
Because untreated pulmonary arterial hypertension (PAH) can lead to right heart failure and death, early diagnosis and treatment are critical. However, diagnosis can be challenging due to the heterogeneous presentation of pulmonary hypertension, delaying timely referral to specialty centers for workup, risk assessment, and treatment. Despite multiple available FDA-approved therapies, many patients do not achieve low-risk status on treatment, worsening their prognosis. To provide optimal patient care, clinicians involved in PAH management should be aware of recent developments, including updated practice guidelines and promising emerging therapies. In this educational activity, experts will review recommended diagnostic strategies, approaches to risk assessment, and evidence-based treatment. Faculty will also examine the latest clinical evidence for emerging agents and discuss strategies for multidisciplinary and interprofessional management to improve the quality of life and outcomes of patients with PAH.
Learning Objectives:
Upon successful completion of this activity, participants should be better able to:
• Review revised guidelines for the use of stepped approaches and algorithms in the diagnosis and treatment of patients with pulmonary arterial hypertension (PAH).
• Differentiate novel advances in the treatment of PAH in terms of mechanism of action, safety, and efficacy.
• Summarize the need for multidisciplinary and interprofessional care teams to improve the overall management and outcomes for patients with PAH.